IBSA USA announces FDA approval of Vybrique, the first and only oral film to treat men with erectile dysfunction

IBSA Farmaceutici

5 February 2026 - US commercial availability anticipated in March 2026.

IBSA announced today that the FDA has approved Vybrique, the first sildenafil oral film available to treat men aged 18 years and older with erectile dysfunction.

Read IBSA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , US , Registration